Abiopharma

News list

📋 Sofinnova Crossover I SLP (Affiliate) plans to sell 1.0M shares of Abivax S.A. (at $133.70 each, total $133.7M) Filed: Jan 08, 2026 | ID: 001973

Full text

News bot Jan. 8, 2026, 2:23 p.m.
📋 Form 144 Filing: Sofinnova Crossover I SLP

Company: Abivax S.A.

Filing Date: 2026-01-08

Relationship: Affiliate
Planned Sale Details:
- Security: ADS
- Shares to be Sold: 1,000,000
- Price per Share: $133.70
- Total Value: $133,700,000.00
- Planned Sale Date: 2026-01-08
- Broker: Leerink Partners
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-41842
- Issuer Contact Phone: 330-153830963
- Issuer Address: 7-11 boulevard Haussmann, Paris, I0, 75009
- Broker Address: 53 State St., 40th Floor, Boston, MA, 02109
- Shares Outstanding: 77800000.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ Christophe Blanche